Zura Bio (ZURA) Interest & Investment Income (2022 - 2026)
Zura Bio's (ZURA) quarterly Interest & Investment Income came in at $1.3 million in Q1 2026, down 27.41% year-on-year from $1.8 million in Q1 2025, and up 3.37% quarter-over-quarter from $1.3 million in Q4 2025.
Zura Bio (ZURA) Interest & Investment Income (2022 - 2026) Analysis & Trends
Zura Bio's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 27.41% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $5.8 million, a 32.12% decrease from a year earlier, with the FY2025 full-year figure at $6.3 million, down 20.78% from the prior year.
- Interest & Investment Income grew to $1.3 million in Q1 2026 per ZURA's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.5 million in Q3 2024 and bottomed at $14.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.3 million (2025), against an average of $1.1 million.
- Across the five-year window, Interest & Investment Income soared 363739.29% in 2023 and sank 39.98% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $7720.0 in 2022, then surged by 17646.11% to $1.4 million in 2023, then surged by 55.18% to $2.1 million in 2024, then tumbled by 39.98% to $1.3 million in 2025, then gained by 3.37% to $1.3 million in 2026.
- Per Business Quant, the three latest ZURA Interest & Investment Income figures stand at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 815,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 7,720.00 |
| Sep 30, 2022 | 224.00 |
| Jun 30, 2022 | 42.00 |
| Mar 31, 2022 | 14.00 |